RFP
IRWD icon

Root Financial Partners’s Ironwood Pharmaceuticals IRWD Stock Holding History

Root Financial Partners’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-133
Closed -$467 – 1793
2026
Q1 		$467 Buy
+133
New +$545 ﹤0.01% 2887

Other funds holding IRWD

WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return

Root Financial Partners's IRWD Position: Q2 2026 in Review

Root Financial Partners sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2026, closing a stake of 133 shares — an estimated $467 sold.

Root Financial Partners first reported a position in IRWD in Q1 2026 and held it in 1 quarter. The position peaked at $467 in Q1 2026. 36 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Root Financial Partners reported no remaining Ironwood Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Root Financial Partners sold 133 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $467.
  • Root Financial Partners first reported a position in Ironwood Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Root Financial Partners's Ironwood Pharmaceuticals position peaked at $467 in Q1 2026.
  • 36 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Root Financial Partners's 13F filing for Q2 2026, filed 29 Jul 2026.